Optogenetic Ribosome and mRNA Display Methods for High-Throughput Screening and Selection of Light-Controlled Binders

Background

The field of protein engineering and molecular recognition has seen significant advancements through the development of display technologies, such as phage, ribosome, and mRNA display, which enable the high-throughput screening of vast libraries of binding proteins against diverse molecular targets. These technologies are foundational for discovering new affinity reagents, therapeutic candidates, and diagnostic tools. However, as biological research and biotechnology increasingly demand more precise and reversible control over molecular interactions—for example, in affinity purification, biosensing, and the creation of responsive biomaterials—there is a growing need for binders whose activity can be dynamically regulated by external stimuli, such as light. Optical binders, which can reversibly associate with their targets in response to specific wavelengths, offer the potential for unprecedented spatial and temporal control in both research and industrial applications.

Despite the promise of optical binders, current approaches to their development are hampered by significant limitations. Traditional methods for generating light-responsive binders typically involve labor-intensive engineering of known binding proteins fused to optogenetic domains, followed by individual characterization of each variant. This process is inherently low-throughput and unsuitable for screening large libraries, making it difficult to identify optimal binders with desired light-switchable properties. Furthermore, conventional display platforms rely on chemical elution to release binders from immobilized targets, which is not compatible with the reversible, non-destructive control required for optical binders. Chemical elution can also introduce harsh conditions that may denature sensitive proteins or disrupt the desired photoswitchable behavior, ultimately limiting the efficiency, scalability, and versatility of current screening and selection strategies.

Technology

This technology is an advanced optogenetic platform that integrates ribosome and mRNA display methods for the high-throughput screening and development of optical binders—proteins engineered to bind and release molecular targets in response to specific light conditions. In this system, large libraries of potential optical binders are linked to their encoding mRNA and ribosome complexes, then incubated with immobilized targets under a defined light condition to enable binding. Instead of using traditional chemical agents for elution, the platform employs a light-triggered mechanism: switching to a second light condition causes the optical binders to release from their targets. The released mRNA is then recovered, reverse transcribed, and amplified, allowing for iterative rounds of selection that enrich for binders with precise, light-dependent binding and release characteristics. This approach is compatible with a wide range of targets and can be adapted for various light wavelengths, making it highly versatile.

The differentiation of this technology lies in its use of light as a selective and reversible trigger for binder release, replacing the conventional reliance on chemical elution. This optogenetic control enables a truly high-throughput and efficient selection process, as it allows for the rapid screening of vast libraries and the direct enrichment of binders with desired photoswitchable properties. Unlike traditional methods that require labor-intensive engineering and individual testing of light-responsive binders, this platform streamlines discovery by enabling parallel selection and optimization. Its ability to generate binders that respond to different light wavelengths further enhances specificity and tunability, opening new possibilities for applications in protein purification, diagnostics, biosensing, and the development of light-controlled therapeutics and biomaterials. The result is a scalable, precise, and broadly applicable solution for the next generation of molecular engineering challenges.

Benefits

• Enables high-throughput screening and selection of optical binders with light-controlled reversible binding properties.
• Uses light as a selective trigger for binder elution, eliminating the need for chemical agents and reducing contamination risks.
• Allows rapid and iterative enrichment of binders that specifically bind under one light condition and release under another, enhancing specificity and control.
• Applicable to a wide range of immobilizable targets, making it versatile for diverse molecular targets.
• Facilitates development of optical binders for light-controlled protein purification, diagnostics, biosensors, and therapeutics.
• Supports scalable and efficient discovery of binders with tunable photoswitchable behaviors across multiple wavelengths.
• Improves protein purification processes by enabling reversible, light-controlled affinity chromatography without harsh chemicals.

Applications

• Light-controlled protein purification
• High-throughput antibody discovery
• Optical biosensors and diagnostics
• Light-responsive therapeutic development
• Industrial enzyme purification

Additional info

This high-throughput method utilizes optogenetic ribosome/mRNA display to screen for optical binders. It enables light-dependent reversible binding to targets. Libraries of binders, linked to their genetic material, are selected by binding under a first light condition and releasing via a switch to a second, allowing iterative enrichment for photoswitchable interactions, replacing chemical elution.